237 related articles for article (PubMed ID: 23551473)
1. Healthcare utilisation and disclosure of injecting drug use among clients of Australia's needle and syringe programs.
Islam MM; Topp L; Iversen J; Day C; Conigrave KM; Maher L
Aust N Z J Public Health; 2013 Apr; 37(2):148-54. PubMed ID: 23551473
[TBL] [Abstract][Full Text] [Related]
2. Are primary health care centres that target injecting drug users attracting and serving the clients they are designed for? A case study from Sydney, Australia.
Islam MM; Topp L; Conigrave KM; White A; Haber PS; Day CA
Int J Drug Policy; 2013 Jul; 24(4):326-32. PubMed ID: 22818978
[TBL] [Abstract][Full Text] [Related]
3. Trust and people who inject drugs: The perspectives of clients and staff of Needle Syringe Programs.
Treloar C; Rance J; Yates K; Mao L
Int J Drug Policy; 2016 Jan; 27():138-45. PubMed ID: 26394538
[TBL] [Abstract][Full Text] [Related]
4. Individual-level syringe coverage among Needle and Syringe Program attendees in Australia.
Iversen J; Topp L; Wand H; Maher L
Drug Alcohol Depend; 2012 May; 122(3):195-200. PubMed ID: 22071120
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus acquisition among injecting drug users: a cohort analysis of a national repeated cross-sectional survey of needle and syringe program attendees in Australia, 1995-2004.
Falster K; Kaldor JM; Maher L;
J Urban Health; 2009 Jan; 86(1):106-18. PubMed ID: 18979201
[TBL] [Abstract][Full Text] [Related]
6. Performance and image enhancing drug injectors' access to needle syringe programs: Responding to a public policy dilemma.
van Beek I; Chronister KJ
Int J Drug Policy; 2015 Sep; 26(9):868-74. PubMed ID: 26118797
[TBL] [Abstract][Full Text] [Related]
7. Representativeness of injecting drug users who participate in HIV surveillance: results from Australia's Needle and Syringe Program Survey.
Topp L; Iversen J; Wand H; Day C; Kaldor J; Maher L;
J Acquir Immune Defic Syndr; 2008 Apr; 47(5):632-8. PubMed ID: 18491422
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus exposure and vaccination in a cohort of people who inject drugs: what has been the impact of targeted free vaccination?
Winter RJ; Dietze PM; Gouillou M; Hellard ME; Robinson P; Aitken CK
J Gastroenterol Hepatol; 2013 Feb; 28(2):314-22. PubMed ID: 23190264
[TBL] [Abstract][Full Text] [Related]
9. Perceived discrimination and injecting risk among people who inject drugs attending Needle and Syringe Programmes in Sydney, Australia.
Wilson H; Brener L; Mao L; Treloar C
Drug Alcohol Depend; 2014 Nov; 144():274-8. PubMed ID: 25236889
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and predictors of injecting-related injury and disease among clients of Australia's needle and syringe programs.
Topp L; Iversen J; Conroy A; Salmon AM; Maher L;
Aust N Z J Public Health; 2008 Feb; 32(1):34-7. PubMed ID: 18290911
[TBL] [Abstract][Full Text] [Related]
11. Patterns of drug use and associated harms among rural injecting drug users: comparisons with metropolitan injecting drug users.
Day C; Conroy E; Lowe J; Page J; Dolan K
Aust J Rural Health; 2006 Jun; 14(3):120-5. PubMed ID: 16706881
[TBL] [Abstract][Full Text] [Related]
12. HIV prevalence and risk behaviour in needle exchange attenders: a national study. The Collaboration of Australian Needle Exchanges.
MacDonald M; Wodak AD; Ali R; Crofts N; Cunningham PH; Dolan KA; Kelaher M; Loxley WM; van Beek I; Kaldor JM
Med J Aust; 1997 Mar; 166(5):237-40. PubMed ID: 9076266
[TBL] [Abstract][Full Text] [Related]
13. Housing instability among people who inject drugs: results from the Australian needle and syringe program survey.
Topp L; Iversen J; Baldry E; Maher L;
J Urban Health; 2013 Aug; 90(4):699-716. PubMed ID: 22733170
[TBL] [Abstract][Full Text] [Related]
14. Association between harm reduction intervention uptake and recent hepatitis C infection among people who inject drugs attending sites that provide sterile injecting equipment in Scotland.
Allen EJ; Palmateer NE; Hutchinson SJ; Cameron S; Goldberg DJ; Taylor A
Int J Drug Policy; 2012 Sep; 23(5):346-52. PubMed ID: 22940142
[TBL] [Abstract][Full Text] [Related]
15. Comparison of needle and syringe programme attendees and non-attendees from a high drug-using area in Sydney, New South Wales.
Cao W; Treloar C
Drug Alcohol Rev; 2006 Sep; 25(5):439-44. PubMed ID: 16939939
[TBL] [Abstract][Full Text] [Related]
16. Drug-related stigma and access to care among people who inject drugs in Vietnam.
Lan CW; Lin C; Thanh DC; Li L
Drug Alcohol Rev; 2018 Mar; 37(3):333-339. PubMed ID: 28762584
[TBL] [Abstract][Full Text] [Related]
17. Opioid dependent patients' experiences of and attitudes towards having their injecting sites examined.
Winstock AR; Nittis M; Whitton G; Lea T
Int J Drug Policy; 2009 Jan; 20(1):85-9. PubMed ID: 18164193
[TBL] [Abstract][Full Text] [Related]
18. Estimating the cost-effectiveness of needle-syringe programs in Australia.
Kwon JA; Anderson J; Kerr CC; Thein HH; Zhang L; Iversen J; Dore GJ; Kaldor JM; Law MG; Maher L; Wilson DP
AIDS; 2012 Nov; 26(17):2201-10. PubMed ID: 22914579
[TBL] [Abstract][Full Text] [Related]
19. Higher HCV antibody prevalence among Indigenous clients of needle and syringe programs.
Ward J; Topp L; Iversen J; Wand H; Akre S; Kaldor J; Maher L
Aust N Z J Public Health; 2011 Oct; 35(5):421-6. PubMed ID: 21973248
[TBL] [Abstract][Full Text] [Related]
20. Needle and syringe sharing practices among injecting drug users in Tehran: a comparison of two neighborhoods, one with and one without a needle and syringe program.
Zamani S; Vazirian M; Nassirimanesh B; Razzaghi EM; Ono-Kihara M; Mortazavi Ravari S; Gouya MM; Kihara M
AIDS Behav; 2010 Aug; 14(4):885-90. PubMed ID: 18483849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
